The governance gap in certified cancer centers: organisational autonomy between clinical and corporate governance
This study reveals a significant governance gap in German, Austrian, and Swiss certified cancer centers, where high clinical and quality management autonomy coexists with constrained financial autonomy, suggesting that certification drives clinical standards but fails to ensure the resource independence necessary for sustainable care.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the complex world of modern healthcare, treating cancer has evolved from a single doctor's task into a massive, coordinated effort. It requires surgeons, radiation experts, and medical oncologists to work together seamlessly, often within large hospital systems. To ensure these teams meet high standards of care, Germany established a voluntary certification system run by the German Cancer Society. This system acts like a rigorous quality seal, checking that a hospital has the right equipment, the right processes, and the right specialists to treat patients effectively. However, a hospital is more than just its medical staff; it is also an organization that must manage money, hire employees, and make strategic decisions. While the certification rules are very specific about how doctors should treat patients, they say very little about how the hospital should be run or who holds the power to make decisions. This creates a potential tension: a center might be excellent at following medical rules but struggle if it lacks the authority to manage the resources needed to keep those rules working.
Researchers from the University of St. Gallen set out to measure this exact tension. They wanted to know how much freedom certified cancer centers actually have to run their own show. Specifically, they looked at "organizational autonomy," which is simply the ability of a center to make its own choices regarding money, staff, technology, and strategy without needing permission from the hospital's main administration. The team surveyed leaders from 177 certified centers across Germany, Austria, and Switzerland, eventually gathering detailed answers from 45 of them. They asked these leaders to rate their independence across seven different areas, creating a score to see where the centers were strong and where they were weak.
The results revealed a striking imbalance, a gap between what the centers are good at and what they struggle to control. The study found that these centers have very high freedom when it comes to quality management. They can decide how to organize their patient care, how to train their staff, and how to monitor their own performance. On average, their score for this type of freedom was very high. However, when it came to financial autonomy, the picture changed completely. The centers had very little control over their own budgets. They could not easily decide how to spend money, hire new staff, or invest in new technology without approval from the larger hospital. The difference between their high freedom in quality and their low freedom in money was the largest gap the researchers found. In fact, the ability to manage quality and the ability to manage money were essentially unrelated; having one did not mean having the other.
This disconnect creates a difficult situation for the people running these centers. They are held responsible for maintaining high standards and passing regular audits, but they often lack the power to secure the funds necessary to do so. The researchers found that this problem was not the same for every hospital. Centers located at university hospitals, which often have access to extra research grants and academic funding, had more financial freedom than those in community hospitals. Similarly, the largest and most comprehensive cancer centers tended to have more money to work with than smaller ones. However, the way a hospital was led—whether by a single boss or a team of leaders—did not seem to change how much freedom the cancer center actually had. The study identified three distinct types of centers based on their overall freedom: a group with high freedom across the board, a group with moderate freedom, and a small group with very restricted freedom, though even the most restricted group still had strong control over their quality management.
The researchers also listened to the open-ended comments from the survey participants, which painted a clear picture of the daily struggle. Many leaders described a frustrating reality where the work of coordinating care, managing data, and ensuring quality generates no direct revenue, yet the costs for this work are not covered by the hospital's main funding. One leader summed up the situation simply by stating there was no autonomy at all. The study suggests that the current system successfully drives high-quality medical care through external rules, but it leaves the financial side of the equation to chance. Without a reliable way to fund the coordination and management that keeps these centers running, the long-term sustainability of this high-quality care is at risk. The authors conclude that while the medical standards are working well, the governance structure needs to evolve to ensure that the people responsible for quality also have the resources to deliver it.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.